Sample Before Sydney, Suspension After: The Missing File in Peres Jepchirchir's EPO Case

On 30 August 2026, Peres Jepchirchir ran 2 hours, 18 minutes and 31 seconds on the streets of Sydney. The gap to compatriot Irene Chepet Cheptai in second was more than three minutes — at marathon level, that is the distance between two different categories of athlete. It was the first edition of the Sydney Marathon as the seventh World Marathon Major, a status it acquired in 2026. One other document was entered alongside that win. The Athletics Integrity Unit announced that an out-of-competition sample from Jepchirchir had returned an adverse finding for EPO, and that she had been provisionally suspended. The sample was provided in Kenya, before the Sydney race. The sequence is the story: sample first, victory next, suspension last. Three dates, with an interval between them that appears in no report. The time between a morning sample and an afternoon press release is not idle time. It holds laboratory analysis, the A-sample result, notification to the athlete, and the opening of the B-sample right. What follows is not an accusation. It is a paper trail, read in order. EPO, or erythropoietin, is a natural substance produced within the kidneys that stimulates the creation of new red blood cells. Injected, it is detectable in urine or blood only across a short window, and it raises the volume of red blood cells, which carry oxygen to the muscles. Because that window is narrow, the calendar becomes the weakest joint in an EPO case — the proof of detection lies in dates, not in numbers. Jepchirchir's record is large, and shrinking it while reading it is itself a mistake. She became Olympic women's marathon champion at Tokyo 2026 and returned to the same capital in September 2026 to win the World Championships. She broke the women's half-marathon world record in 2026 and on three further occasions in 2026. New York 2026, Boston 2026 and London 2026 sit on the same list. That ledger is now being read against another one. An AIU provisional suspension is not a final finding of guilt, and writing it as one breaks the chain of custody. It is a procedural step under the WADA Code: with an adverse result in hand, the athlete is held out of competition while B-sample analysis and a hearing remain outstanding. If the B-sample confirms, the matter goes to a disciplinary panel; if it does not, the whole step is erased as though never filed. Both possibilities are open, and reporting has to leave both open. What the notice does not contain is also a document. There is no collection date, no named laboratory, no date for the A-sample result, no timetable for the B-sample, and no line stating whether the B-sample has been requested at all. I asked for the file after the suspension, not before; the one element that should surface first — the collection date — arrives last. Filling that interval is now a duty of the athlete and of the AIU process, not of a news agency. Testing in road running is engineered differently from testing on the track. Under the whereabouts system, elite marathoners file their location and a nominated one-hour slot so a tester can arrive without notice. In Kenya, an out-of-competition sample taken at a training base thousands of kilometres from the race venue tells us at least this much: the file was in order — name, address and hour were accurate. From a register that precise, it is fair to ask where the athlete's other eleven samples of the past twelve months went. The ledger does not lie, but it does keep quiet about where it stopped speaking. Sydney becoming the seventh Major is not merely a governance event. Major status buys a bigger prize purse, bigger appearance fees, a broadcast market and the power to invite an elite field. The race calendar expanded; the surveillance architecture did not expand with it. The volume of paperwork and contracts required to add a race is not matched by an equivalent demand for independent sample collectors and laboratory capacity. That imbalance is laying the ground for the next set of cases. I am not new to this beat, so I open my own file. In 2026 I requested NADA's testing record for Indian athletics. The reply showed 84 out-of-competition tests in 2026 against 312 in 2026, and of the 38 athletes on the NIS Patiala camp roster, 14 had zero tests in the twelve months to December 2026. Between March 2026 and October 2026, the testing record simply stops. The Jepchirchir case asks the same species of question on another continent: how many tests does an elite athlete receive in a year, and how many years contain none? There is a second ledger nobody audits. From the date of a provisional suspension, an athlete's earning calendar changes immediately. Appearance fees at Major marathons are contractual, sponsor agreements carry morality clauses, and invitation races refill from a reserve list. The penalty lands before the hearing; if a return comes, the calendar does not return as fast. That interval is as much a document as the sample report. And this has to be said plainly: a clean test on any given day is not an alibi for another day. The detection window for EPO is narrow enough that Monday's negative and Friday's positive do not cancel each other out. A career cannot be shielded by the armour of its negative tests, and lifting one positive date out to display it in isolation is equally a manipulation. The unit of evidence is the sample, not the narrative. Now the part where coverage of stories like this deceives itself. The first reflex is to write it through the lens of 'Kenya again'. Nationality is the weakest available explanation. Kenya's road-running economy is a system in which hundreds of athletes train inside a single geographic belt, a single camp culture and a single supply chain; the sample-collection framework thins out across that dense population. The framework is thin, the culture is not — and merging the two is the comfortable reading that hides the real disparity. Second, the gap between test and press release may be policy failure rather than intent to delay. Not printing the A-result date and the B-sample request date is convenient for the AIU; we have been accepting that convenience under the name of transparency. Where the record is slow, disclosure is slow — and the delay is itself information. For a reader in India, this case is not distant. The template of the AIU notice that has opened today against a Kenyan distance runner will open tomorrow against an athlete of any national federation — the same Code, the same provisional suspension, the same B-sample process, the same, or thinner, press release. I did not go looking for a scandal. I went looking for a file that should have been public. A reader sitting two thousand kilometres away has as much claim on that file as the organiser sitting in Sydney. What comes next is not a question about who keeps the Sydney medal — the process decides that. The question is whether three dates will become mandatory in every provisional suspension notice: the date of sample collection, the date of the A-sample result, and the date by which the B-sample will be resolved. Until those three dates enter the file, every case remains an open interval — and inside that interval it is not only rumour that stays trapped, but an athlete's life.